NCT06311110

Brief Summary

This cross-sectional case-control study aimed to determine whether there is a significant difference in the prevalence of impaired toilet training, LUTS, and functional bowel problems among children diagnosed with DCD and typically developing children (TDC).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
84

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2023

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 14, 2023

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

March 7, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 15, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

August 2, 2024

Status Verified

August 1, 2024

Enrollment Period

2.2 years

First QC Date

March 7, 2024

Last Update Submit

August 1, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Impaired toilet training

    Prevalence of impaired toilet training in children with DCD compared to TDC

    through study completion, 25 minutes

  • Daytime incontinence

    Prevalence of daytime incontinence at 5 years old in children with DCD compared to TDC

    through study completion, 25 minutes

  • Enuresis

    Prevalence of enuresis at 5 years old in children with DCD compared to TDC

    through study completion, 25 minutes

  • Fecal incontinence

    Prevalence of fecal incontinence at 4 years old in children with DCD compared to TDC

    through study completion, 25 minutes

Secondary Outcomes (2)

  • Toilet training difficulties

    through study completion, 25 minutes

  • General bladder and bowel dysfunction

    through study completion, 25 minutes

Study Arms (2)

DCD case group

The case group consists of children with developmental coordination disorder.

Other: Vancouver symptom score for dysfunctional elimination symptoms QuestionnaireOther: Developmental Coordination Disorder QuestionnaireOther: Questionnaire concerning impaired toilettraining and comorbities

TDC control group

The control group consists of typically developing children, grade and gender matched with the DCD case group.

Other: Vancouver symptom score for dysfunctional elimination symptoms QuestionnaireOther: Developmental Coordination Disorder QuestionnaireOther: Questionnaire concerning impaired toilettraining and comorbities

Interventions

Vancouver symptom score for dysfunctional elimination syndrome, Dutch version, validated by 't Hoen et al. 2016. The questionnaire is filled in by the parents of the child.

Also known as: VSSDES
DCD case groupTDC control group

Validated Developmental Coordination Disorder Questionnaire, Dutch version includes assessment of motor functioning. The questionnaire is filled in by the parents of the child.

Also known as: DCD-Q, CVO
DCD case groupTDC control group

Unvalidated, complementary questions concerning impaired toilettraining and comorbidities. Questions were based on ICCS standardisation guidelines (Austin et al., 2015). The questionnaire is filled in by the parents of the child.

DCD case groupTDC control group

Eligibility Criteria

Age5 Years - 8 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children with developmental coordination disorder and grade- and gender matched typically developing children.

You may qualify if:

  • Diagnosed with DCD by a multidisciplinary team (DCD case group)
  • Children with a typical development, grade and gender matched with the DCD case group (TDC control group).

You may not qualify if:

  • A DCD-Q score indicative for DCD (TDC control group)
  • Presence of other developmental disorders, such as ASS, ADHD or intellectual disability (TDC control group)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ghent University Hospital/Ghent University

Ghent, East Flanders, 9000, Belgium

RECRUITING

University Hospital Ghent

Ghent, Belgium

RECRUITING

MeSH Terms

Conditions

Motor Skills DisordersLower Urinary Tract SymptomsIntestinal Diseases

Condition Hierarchy (Ancestors)

Neurodevelopmental DisordersMental DisordersUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Ellen Vandamme, MD

    University Hospital, Ghent

    PRINCIPAL INVESTIGATOR
  • Bieke Samijn, PhD

    University Ghent

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Bieke Samijn, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 7, 2024

First Posted

March 15, 2024

Study Start

March 14, 2023

Primary Completion

June 1, 2025

Study Completion

June 1, 2025

Last Updated

August 2, 2024

Record last verified: 2024-08

Locations